Glyburide for the management of gestational diabetes: Risk factors predictive of failure and associated pregnancy outcomes
Authors:
- 1 October 2006
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 195 (4) , 1090-1094
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organizationAmerican Journal of Obstetrics and Gynecology, 2005
- Insulin and glyburide therapy: Dosage, severity level of gestational diabetes, and pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 2005
- Management of Diabetes Mellitus by Obstetrician–GynecologistsObstetrics & Gynecology, 2004
- Prospective Observational Study to Establish Predictors of Glyburide Success in Women with Gestational Diabetes MellitusJournal of Perinatology, 2004
- Use of glyburide for the treatment of gestational diabetes: the San Antonio experienceThe Journal of Maternal-Fetal & Neonatal Medicine, 2004
- Glyburide Compared to Insulin for the Treatment of Gestational Diabetes Mellitus: A Cost AnalysisJournal of Perinatology, 2002
- Oral hypoglycemic agents in pregnancy: their time has comeThe Journal of Maternal-Fetal & Neonatal Medicine, 2002
- DIABETES COMPLICATING PREGNANCYObstetrics and Gynecology Clinics of North America, 2001
- A Comparison of Glyburide and Insulin in Women with Gestational Diabetes MellitusNew England Journal of Medicine, 2000
- Identification and Treatment of Women with Hyperglycaemia Diagnosed During Pregnancy Can Significantly Reduce Perinatal Mortality Rates*Australian and New Zealand Journal of Obstetrics and Gynaecology, 1996